Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer
Work
Year: 2023
Type: article
Source: Cancer Immunology Immunotherapy
Institution Asahikawa Medical University
Cites: 52
Cited by: 6
Related to: 10
FWCI: 1.256
Citation percentile (by year/subfield): 99.99
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green